In a series of live web casts, the biopharmaceutical industry’s leading Clinical Technology Organization will examine the practical application of technology to capture Patient Reported Outcomes. ClinPhone will present several online, interactive sessions to provide sponsors with an opportunity to learn from their extensive experience in over 120 studies involving Electronic Patient Diary (EPD) applications. The webinars will be delivered in November to audiences around the world on the following dates:

13th November 2003: 10-10.30 am GMT
14th November 2003: 11-11.30 am EST (4:00-4:30 pm GMT)
17th November 2003: 2-2.30 pm GMT (9:00-9:30 EST)
18th November 2003: 2-2.30 pm EST

These 30-minute sessions will be delivered by ClinPhone’s Product Development Director Dr. Bill Byrom in the UK and by ClinPhone’s Director of Strategic Business Development David Stein in the United States. Both have published articles on the use of Interactive Voice Response (IVR) and handheld devices in collecting patient data and are acknowledged experts in electronic Patient Reported Outcomes (ePRO).

Commenting on the purpose of the webinars David Stein said, “There is no doubt that electronic diaries greatly improve the quality of patient reported data. However, less than one out of every twenty patient diaries is captured electronically. Through these web casts, we hope to provide Sponsors with practical information to help them plan and design effective ePRO studies.”

The webinars will compare and contrast telephone-based patient diary solutions, electronic device applications and paper diaries. The sessions will also examine how electronic diary technologies have resolved many regulatory issues and the concerns that remain for the agencies. Additionally, the webinars will present Patient Direct, ClinPhone’s IVR diary solution and overview its key features and properties.

Anyone wishing to participate in the webinar can register at www.patient-diary.com.

ends

For further information, please contact:

Richard Gee +44 115 9508399 This email address is being protected from spambots. You need JavaScript enabled to view it.
Sally Kent +44 115 9557333 This email address is being protected from spambots. You need JavaScript enabled to view it.

ABOUT CLINPHONE
• ClinPhone is the largest and most experienced technology provider in the pharmaceutical industry having supported more than 900 clinical trials (of which more than 300 are currently live) in over 80 countries and almost 70 languages. The workforce has grown from just a handful in the company's early days to more than 360 today. ClinPhone has no less than 15 coveted preferred supplier agreements and its system handles in excess of 90,000 calls per month.

• The company’s headquarters in Nottingham, UK, now occupies four individual facilities with a separate technical facility dedicated to innovative research and development.

• More than 80 client-facing members of staff also work in offices throughout the United States serving commercial demand that represents 60% of ClinPhone's revenue returns. Most of these staff now occupy new premises in Princeton and Chicago as the amount of business and number of clients continues to increase. There are also two central European facilities in Brussels, Belgium and Heidelberg, Germany.

• ClinPhone has recently secured an exclusive, worldwide, perpetual license with Healthcare Technology Systems Inc. (HTS) for the use of HTS' instruments on any patient diary device or medium used in Phase I - IV clinical trials funded by pharmaceutical, biotechnology or medical device companies.


THIS RELEASE HAS BEEN DISTRIBUTED BY WEBITPR (www.webitpr.com)

Disclaimer:

Whilst WebitPR Ltd endeavour to ensure the accuracy of the information contained in this Release, WebitPR Ltd cannot accept any liability for:-

• the inaccuracy or otherwise of any information contained in this Release; or
• any loss liability or expense which may be suffered by any party in consequence of acting or omitting to act as a result of any information contained in or omitted from this Release.; or
• any loss or suffering which may be caused by or to any party either as a result of the information contained in this Release or such information contained in this Release being inaccurate or otherwise misleading.

In the event that any information contained in this Release is inaccurate or misleading then please contact WebitPR at the above e-mail address.